Artwork

Contenido proporcionado por Haydn Brain & Ed Gotham, Haydn Brain, and Ed Gotham. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Haydn Brain & Ed Gotham, Haydn Brain, and Ed Gotham o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

Jeff Desjardins - Space, Gene Editing, & Signals Gaining Momentum in the 'Exponential Age'

49:50
 
Compartir
 

Manage episode 394733566 series 2715815
Contenido proporcionado por Haydn Brain & Ed Gotham, Haydn Brain, and Ed Gotham. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Haydn Brain & Ed Gotham, Haydn Brain, and Ed Gotham o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

Get OPTO's best content every day by subscribing to our FREE Newsletter: www.cmcmarkets.com/en/opto/newsletter
Welcome back! Today, we have the pleasure of hosting Jeff Desjardins, Editor-in-Chief of Visual Capitalist & author of the 2021 book ‘Signals: The 27 Trends Defining the Future of the Global Economy.’

In this episode, Jeff maps out the trajectory of the 'Exponential Age,' spotlighting the impact of the new space race, the genomics revolution, and the relentless pace of accelerating technology.
We kick off the conversation by exploring the challenges of discerning signals from noise in today's fast-paced world. Jeff shares insights into the key factors fuelling demand for space-related products and services, highlighting major players in global satellite distribution, such as SpaceX. Delving into genomics, he highlights significant milestones, including the recent FDA approval of the first CRISPR cell therapy designed to treat sickle cell disease. Jeff also discusses potential breakthroughs in areas like cancer treatment, where CRISPR's revolutionary capabilities hold immense promise. Finally, he explains the ‘signal range’ and ‘signal-to-noise ratio’ scores assigned to both themes in his book before sharing his take on the next big idea. Enjoy!
Check out this infographic on thematic investing Visual Capitalist created for OPTO.
- Listen to our previous episode featuring Jeff Desjardins:
Apple Podcasts
Spotify
- Listen to our Rocket Lab interview:
Apple Podcasts
Spotify
- Listen to our ARK Invest's Ali Urman interview on the genomic revolution:
Apple Podcasts
Spotify
Check out our daily newsletter: https://www.cmcmarkets.com/en/opto/newsletter

---------
Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment, or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction, or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independen

-----
The content in this podcast is for informational purposes only. Opto Markets LLC does not recommend any specific securities or investment strategies. Investing involves risk & investments may lose value, including the loss of principal. Past performance does not guarantee future results. Investors should consider their investment objectives and risks carefully before investing. The information provided is not an endorsement of this product and is for information and/or educational purposes only.

  continue reading

241 episodios

Artwork
iconCompartir
 
Manage episode 394733566 series 2715815
Contenido proporcionado por Haydn Brain & Ed Gotham, Haydn Brain, and Ed Gotham. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Haydn Brain & Ed Gotham, Haydn Brain, and Ed Gotham o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

Get OPTO's best content every day by subscribing to our FREE Newsletter: www.cmcmarkets.com/en/opto/newsletter
Welcome back! Today, we have the pleasure of hosting Jeff Desjardins, Editor-in-Chief of Visual Capitalist & author of the 2021 book ‘Signals: The 27 Trends Defining the Future of the Global Economy.’

In this episode, Jeff maps out the trajectory of the 'Exponential Age,' spotlighting the impact of the new space race, the genomics revolution, and the relentless pace of accelerating technology.
We kick off the conversation by exploring the challenges of discerning signals from noise in today's fast-paced world. Jeff shares insights into the key factors fuelling demand for space-related products and services, highlighting major players in global satellite distribution, such as SpaceX. Delving into genomics, he highlights significant milestones, including the recent FDA approval of the first CRISPR cell therapy designed to treat sickle cell disease. Jeff also discusses potential breakthroughs in areas like cancer treatment, where CRISPR's revolutionary capabilities hold immense promise. Finally, he explains the ‘signal range’ and ‘signal-to-noise ratio’ scores assigned to both themes in his book before sharing his take on the next big idea. Enjoy!
Check out this infographic on thematic investing Visual Capitalist created for OPTO.
- Listen to our previous episode featuring Jeff Desjardins:
Apple Podcasts
Spotify
- Listen to our Rocket Lab interview:
Apple Podcasts
Spotify
- Listen to our ARK Invest's Ali Urman interview on the genomic revolution:
Apple Podcasts
Spotify
Check out our daily newsletter: https://www.cmcmarkets.com/en/opto/newsletter

---------
Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment, or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction, or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independen

-----
The content in this podcast is for informational purposes only. Opto Markets LLC does not recommend any specific securities or investment strategies. Investing involves risk & investments may lose value, including the loss of principal. Past performance does not guarantee future results. Investors should consider their investment objectives and risks carefully before investing. The information provided is not an endorsement of this product and is for information and/or educational purposes only.

  continue reading

241 episodios

Alle episoder

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida